Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 16,654,000 | 14,653,000 | 13,715,000 | 17,763,000 | 17,702,000 |
| Cost of Goods | 4,172,000 | 3,778,000 | 2,845,000 | 5,909,000 | 5,263,000 |
| Gross Profit | 12,482,000 | 10,875,000 | 10,870,000 | 11,854,000 | 12,439,000 |
| Operating Expenses | 8,631,000 | 7,092,000 | 7,132,000 | 9,507,000 | 7,480,000 |
| Operating Income | 3,851,000 | 3,783,000 | 3,738,000 | 2,347,000 | 4,959,000 |
| Other Income | -517,000 | -739,000 | -953,000 | -2,357,000 | -244,000 |
| Pre-tax Income | 3,334,000 | 3,044,000 | 2,785,000 | -10,000 | 4,715,000 |
| Income Tax | -216,000 | 141,000 | -189,000 | -421,000 | 234,000 |
| Net Income Continuous | 3,550,000 | 2,903,000 | 2,973,000 | 411,000 | 4,481,000 |
| Net Income Discontinuous | 0 | 25,000 | 0 | 7,000 | -8,000 |
| Minority Interests | 9,000 | 18,000 | 6,000 | 8,000 | 8,000 |
| Net Income | $3,541,000 | $2,910,000 | $2,967,000 | $410,000 | $4,465,000 |
| EPS Basic Total Ops | 0.62 | 0.51 | 0.52 | 0.07 | 0.79 |
| EPS Basic Continuous Ops | 0.62 | 0.51 | 0.52 | 0.07 | 0.79 |
| EPS Diluted Total Ops | 0.62 | 0.51 | 0.52 | 0.07 | 0.78 |
| EPS Diluted Continuous Ops | 0.62 | 0.51 | 0.52 | 0.06 | 0.79 |
| EPS Diluted Before Non-Recurring Items | 0.87 | 0.78 | 0.92 | 0.63 | 1.06 |
| EBITDA(a) | $5,513,000 | $5,408,000 | $5,356,000 | $4,138,000 | $6,714,000 |